TWIST1 and breast carcinoma: Importantly, we describe for the first time the ability of melatonin to counteract the stimulatory effect of doxorubicin on TWIST1 (Twist-related protein 1) expression and protein levels in estrogen-dependent but not in estrogen-independent breast cancer cells.